Open Access study in Europe shows ~10% of articles published in OA journals

 Study of Open Access Publishing project presents findings of two-year EC funded study on OA publishing17 Jan 2011

The SOAP (Study of Open Access Publishing) project presented the results of its two-year European Commission (EU) funded examination of open access publishing at an open symposium on January 13, 2011, in Berlin, Germany. Over the two-year study duration, the SOAP project performed a comprehensive study of open access journals, publishers and business models, including analysis of publishing houses, learned societies and licensing along with the overall supply and demand for open access.

The study surveyed over 50,000 researchers for their opinions on open-access journals, which make all their papers freely available online and usually charge authors a fee for each published paper. According to the study, while scientists like open-access papers as readers, as authors, they are still skeptical. The study found overwhelming support for the concept, with 89 percent of respondents stating that open access is beneficial to their field. However, this support did not always translate into action, the study noted. While 53 percent of respondents said they had published at least one open-access article, overall only about 10 percent of papers are published in open access journals.

The study found two main reasons as to why researchers do not submit their work to open-access journals. About 40 percent said that a lack of funding for author fees was a deterrent, while 30 percent cited a lack of high-quality open-access journals in their field.

Requiring authors to make sure the results of their work are freely available has reportedly had only partial success. Robert Kiley, head of digital services at the Wellcome Trust’s Wellcome Library in London, said at the symposium that open-access rates had risen from 12 percent to 50 percent since the funder began requiring its grantees to publish in open-access journals or deposit their papers in a freely available repository. However, Kiley acknowledged that Wellcome Trust had not imposed sanctions on researchers who failed to comply.

The study also makes it clear that open-access journals are proliferating, especially among small publishers. It was observed that one-third of open-access papers were published by the more than 1600 open-access publishers that publish only a single journal. The study also identified 14 ‘large publishers’ that publish either more than 50 journals or more than 1000 articles per year. The group accounts for roughly one-third of open-access publications, the study noted.”

Source:  Knowledgespeak Newsletter, 1/17/11

Open Access & Article Depostion from Nature Pub. Group

 Nature Publishing Group and ASGT announce open access and article deposition services for authors – 26 Jan 2009

Scientific publisher Nature Publishing Group (NPG), UK, and the American Society of Gene Therapy (ASGT) have announced the launch of two new services to help authors comply with funder and institutional mandates for public access. Under the initiative, Molecular Therapy, the official journal of the ASGT, will now offer authors the option of immediate open access on publication, including deposition in PubMed Central, subject to the payment of a publication fee. In addition, as a further author benefit to aid compliance with several funding body mandates, NPG will deposit all Molecular Therapy articles to PubMed Central upon final publication, to be made public after 12 months.

Upon submission of original research articles, authors have the option of publishing their articles as open access for a publication fee of £2,000 / $3,000 / €2,400. Open access articles will be freely available upon publication. By paying this one-time fee, authors are also entitled to self-archive the final published PDF of their articles on a website, institutional repository, or other free public server upon publication. Open access articles will be designated by the MTOpen logo in both the print and online editions of the journal and will be freely accessible via PubMed Central immediately after publication.

Open access articles will be published under a Creative Commons license. Authors may choose between the Attribution-Noncommercial-No Derivative Works 3.0 Unported and the Attribution-Noncommercial-Share Alike 3.0 Unported Licence. The Attribution-Noncommercial-Share Alike Licence permits derivative works, ensuring that authors can comply with funders such as the Wellcome Trust. Under both licenses, the final published version of MTOpen articles can be downloaded and shared as long as the author and original publication are cited.

Under the terms of NPG’s License to Publish, self-archiving is encouraged on all original research articles published in Molecular Therapy. In all cases, the author’s version of the accepted manuscript can be made publicly accessible six months after publication. This applies regardless of whether the authors choose the MTOpen option.

Molecular Therapy joins The EMBO Journal, EMBO reports and British Journal of Cancer, which already offer an open access option to authors. NPG also announced the introduction of an open access option on ten further journals.

Click here

Knowledgespeak Newsletter, 26 Jan., 2009